IBDEI0EI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6675,1,4,0)
 ;;=4^Z85.118
 ;;^UTILITY(U,$J,358.3,6675,2)
 ;;=^5063408
 ;;^UTILITY(U,$J,358.3,6676,0)
 ;;=Z85.21^^30^397^91
 ;;^UTILITY(U,$J,358.3,6676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6676,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Larynx
 ;;^UTILITY(U,$J,358.3,6676,1,4,0)
 ;;=4^Z85.21
 ;;^UTILITY(U,$J,358.3,6676,2)
 ;;=^5063411
 ;;^UTILITY(U,$J,358.3,6677,0)
 ;;=Z85.3^^30^397^85
 ;;^UTILITY(U,$J,358.3,6677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6677,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,6677,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,6677,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,6678,0)
 ;;=Z85.41^^30^397^87
 ;;^UTILITY(U,$J,358.3,6678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6678,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,6678,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,6678,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,6679,0)
 ;;=Z85.43^^30^397^95
 ;;^UTILITY(U,$J,358.3,6679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6679,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,6679,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,6679,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,6680,0)
 ;;=Z85.46^^30^397^96
 ;;^UTILITY(U,$J,358.3,6680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6680,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,6680,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,6680,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,6681,0)
 ;;=Z85.47^^30^397^100
 ;;^UTILITY(U,$J,358.3,6681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6681,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,6681,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,6681,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,6682,0)
 ;;=Z85.51^^30^397^84
 ;;^UTILITY(U,$J,358.3,6682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6682,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bladder
 ;;^UTILITY(U,$J,358.3,6682,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,6682,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,6683,0)
 ;;=Z85.528^^30^397^89
 ;;^UTILITY(U,$J,358.3,6683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6683,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,6683,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,6683,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,6684,0)
 ;;=Z85.6^^30^397^80
 ;;^UTILITY(U,$J,358.3,6684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6684,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,6684,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,6684,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,6685,0)
 ;;=Z85.72^^30^397^104
 ;;^UTILITY(U,$J,358.3,6685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6685,1,3,0)
 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
 ;;^UTILITY(U,$J,358.3,6685,1,4,0)
 ;;=4^Z85.72
 ;;^UTILITY(U,$J,358.3,6685,2)
 ;;=^5063436
 ;;^UTILITY(U,$J,358.3,6686,0)
 ;;=Z85.79^^30^397^94
 ;;^UTILITY(U,$J,358.3,6686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6686,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
 ;;^UTILITY(U,$J,358.3,6686,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,6686,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,6687,0)
 ;;=Z85.820^^30^397^83
 ;;^UTILITY(U,$J,358.3,6687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6687,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,6687,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,6687,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,6688,0)
 ;;=Z85.828^^30^397^98
 ;;^UTILITY(U,$J,358.3,6688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6688,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
